Fostamatinib disodium
C-935788-047
Phase 3 small_molecule completed
Quick answer
Fostamatinib disodium for Immune Thrombocytopenic Purpura is a Phase 3 program (small_molecule) at RIGEL PHARMACEUTICALS INC with 3 ClinicalTrials.gov record(s).
Program details
- Company
- RIGEL PHARMACEUTICALS INC
- Indication
- Immune Thrombocytopenic Purpura
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed